Edward M. Greenfield

机构：University of Indianapolis, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis · ORCID：0000-0002-0921-983X

发表论文 118 篇 · 总被引 4683 次 · h-index 37

代表论文

Dual CDK4/6–PI3K/mTOR inhibition reinforces cytostatic programs and tumor control in preclinical models of primary and metastatic osteosarcoma (2026 · Neoplasia · 被引 4)
Repurposing Romidepsin for Osteosarcoma: Screening FDA-Approved Oncology Drugs with Three-Dimensional Osteosarcoma Spheroids (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)
Halicin‑Rifampicin Combinations Are More Effective Than Monotherapy Against Biofilm‑Residing Staphylococcus Aureus and Prevent Emergence of Rifampicin Resistance (2026 · European Cells and Materials)
Figure 5 from Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma (2025)
Figure S8 from Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma (2025)
Figure S1 from Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma (2025)